Shift Health was engaged by Baycrest Health Sciences to develop a business plan and operating model for the multinational, multi-partner Centre for Aging and Brain Health Innovation (CABHI).
Case Study
Demonstrating the Impact of OSSU’s Model for Fortifying Patient-Oriented Research
Ontario SPOR SUPPORT Unit (OSSU) needed to develop and pilot an evaluation tool to assess the impact of its multi-sectoral approach to patient-oriented research at the midpoint of its funding cycle.
Creating the Personalized Healthcare System of the Future
A global biopharmaceutical company recognized the need to work in partnership with healthcare systems in order to realize the vital, long-term potential of a personalized approach to healthcare.
Assessing the Market for Novel Image Guidance Systems for Minimally Invasive Cardiac Interventions
An Asian specialty healthcare company needed to assess the US market for novel image guidance medical device systems for minimally invasive cardiac interventions.
Spearheading a Canadian Coalition to Eliminate The Threat of Drug-Resistant Infections
McMaster University sought to establish a Canadian network focused on advancing innovative solutions to drug-resistant infections.
Inspiring Meaningful Change for a University’s Communities
The University of Saskatchewan engaged Shift Health to develop a strategic plan that would tell an authentic story, inspire diverse communities and provide an accessible and engaging means to understanding the institution.
Advancing a Pharmaceutical-Grade Cannabis Portfolio Positioned to Address Health Needs
A player in the medical cannabis space required support to uncover and catalogue scientific evidence that established the link between specific cannabis-based metabolites and their therapeutic benefit.
Securing $15M for a Microbiome Research and Drug Discovery Program
McMaster University sought to secure a $15M investment to support the creation of a research program focused on studying host microbe interactions and the development of new antimicrobial agents.
Evaluating the Current State of Cancer Clinical Trials in Canada
The Canadian Cancer Research Alliance (CCRA) wanted to better understand the cancer clinical trial landscape in Canada, and in particular, the contribution of its initiatives to promoting access to trials.